Published in J Immunol Res on January 09, 2017
IL-17 and Th17 Cells. Annu Rev Immunol (2009) 23.02
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med (2007) 10.00
Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol (2006) 9.53
Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol (2006) 9.42
Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology (1970) 6.06
Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol (2007) 3.65
Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue. Gut (2008) 2.97
In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations. Blood (2008) 2.24
IL-17 contributes to CD4-mediated graft-versus-host disease. Blood (2008) 2.07
CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome. J Immunol (2004) 2.00
Deficiency of CD73/ecto-5'-nucleotidase in mice enhances acute graft-versus-host disease. Blood (2012) 1.72
CD39 and control of cellular immune responses. Purinergic Signal (2007) 1.68
Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new. Blood (2011) 1.30
Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation. Eur J Immunol (2008) 1.28
Stem cell mobilization with G-CSF induces type 17 differentiation and promotes scleroderma. Blood (2010) 1.24
Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantation. Blood (2012) 1.12
CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity. J Immunol (2012) 1.12
Generation and regulation of CD8(+) regulatory T cells. Cell Mol Immunol (2008) 1.11
Hyperacute GVHD: risk factors, outcomes, and clinical implications. Blood (2007) 1.10
Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance. Blood (2004) 1.09
Cutaneous GVHD is associated with the expansion of tissue-localized Th1 and not Th17 cells. Blood (2010) 1.07
IL-17-producing T cells contribute to acute graft-versus-host disease in patients undergoing unmanipulated blood and marrow transplantation. Eur J Immunol (2011) 1.03
Human CD8+ regulatory T cells inhibit GVHD and preserve general immunity in humanized mice. Sci Transl Med (2013) 1.00
CD8 regulatory T cells: what's old is now new. Immunol Cell Biol (2009) 0.92
Cytokine expression during acute graft-versus-host disease after allogeneic peripheral stem cell transplantation. Bone Marrow Transplant (2005) 0.91
Targeting the IL17 pathway for the prevention of graft-versus-host disease. Biol Blood Marrow Transplant (2014) 0.90
CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients. Hum Immunol (2010) 0.90
CD4+ regulatory cells as a potential immunotherapy. Philos Trans R Soc Lond B Biol Sci (2005) 0.90
Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease. J Immunol (2015) 0.88
Functionally suppressive CD8 T regulatory cells are increased in patients with multiple myeloma: a cause for immune impairment. PLoS One (2012) 0.88
FoxP3- and CD8-positive Infiltrating Immune Cells Together Determine Clinical Outcome in Colorectal Cancer. Cancer Microenviron (2011) 0.88
Phenotypic and functional characteristic of a newly identified CD8+ Foxp3- CD103+ regulatory T cells. J Mol Cell Biol (2013) 0.86
Human regulatory T cells of G-CSF mobilized allogeneic stem cell donors qualify for clinical application. PLoS One (2012) 0.86
Ovarian carcinoma-infiltrating regulatory T cells were more potent suppressors of CD8(+) T cell inflammation than their peripheral counterparts, a function dependent on TIM3 expression. Tumour Biol (2015) 0.84
Kinetic analysis of cytokine gene expression in patients with GVHD after donor lymphocyte infusion. Bone Marrow Transplant (2001) 0.81
Graft-versus-host disease is enhanced by selective CD73 blockade in mice. PLoS One (2013) 0.81
G-CSF reduces IFN-gamma and IL-4 production by T cells after allogeneic stimulation by indirectly modulating monocyte function. Bone Marrow Transplant (2000) 0.81
Cytokine profiles in various graft-versus-host disease target organs following hematopoietic stem cell transplantation. Cell Transplant (2012) 0.80
Interferon-Beta Therapy of Multiple Sclerosis Patients Improves the Responsiveness of T Cells for Immune Suppression by Regulatory T Cells. Int J Mol Sci (2015) 0.79
FOXP3+ and CD39+ regulatory T cells in subtypes of cutaneous lupus erythematosus. J Eur Acad Dermatol Venereol (2015) 0.79
Lymphocyte effector functions: armed for destruction? Curr Opin Immunol (2007) 0.78
IL-17 gene ablation does not impact Treg-mediated suppression of graft-versus-host disease after bone marrow transplantation. Biol Blood Marrow Transplant (2013) 0.78
Flow cytometry-based enumeration and functional characterization of CD8 T regulatory cells in patients with multiple myeloma before and after lenalidomide plus dexamethasone treatment. Cytometry B Clin Cytom (2013) 0.78
Granulocyte colony-stimulating factor produces a decrease in IFNgamma and increase in IL-4 when administrated to healthy donors. J Clin Apher (2010) 0.77
Dynamic regulation of effector IFN-γ-producing and IL-17-producing T cell subsets in the development of acute graft-versus-host disease. Mol Med Rep (2015) 0.76